← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2004Last known activity
Aug 20, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 5 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (6)
- NCT06440629CollaboratorPhase 4Aug 20, 2024
- NCT06084364OfficialPhase 4Nov 3, 2023
- NCT06084364CollaboratorPhase 4Nov 3, 2023
- NCT02689986Study chairPhase 2Jan 1, 2013
- NCT00437346Overall official - principal investigatorN/AJan 1, 2007
- NCT00360906Overall official - principal investigatorPhase 2/Phase 3Dec 1, 2004
Details
- Last known activity
- Aug 20, 2024